AbstractThere is increasing interest in the use of omega-3 supplements to reduce aggressive behavior. This meta-analysis summarizes findings from 29 RCTs (randomized controlled trials) on omega-3 supplementation to reduce aggression, yielding 35 independent samples with a total of 3918 participants. Three analyses were conducted where the unit of analysis was independent samples, independent studies, and… Continue reading #Omega-3 supplementation reduces aggressive #behavior: A meta-analytic review of randomized controlled trials
Category: Psychiatry
#Neuropsychiatric prodromes and symptom timings in relation to disease onset and/or flares in #SLE: results from the mixed methods international INSPIRE study
BackgroundNeuropsychiatric symptoms in SLE and other systemic autoimmune rheumatic diseases (SARDs) are challenging to diagnose, attribute and manage. We investigated the timings of onset of a broad range of neuropsychiatric (NP) symptoms in relation to timing of SLE onset. In addition, we explored whether NP symptoms may be a prodrome to SARD onset and to… Continue reading #Neuropsychiatric prodromes and symptom timings in relation to disease onset and/or flares in #SLE: results from the mixed methods international INSPIRE study
Age-dependent association of #cannabis use with risk of #psychotic disorder
BackgroundEpidemiologic research suggests that youth cannabis use is associated with psychotic disorders. However, current evidence is based heavily on 20th-century data when cannabis was substantially less potent than today.MethodsWe linked population-based survey data from 2009 to 2012 with records of health services covered under universal healthcare in Ontario, Canada, up to 2018. The cohort included… Continue reading Age-dependent association of #cannabis use with risk of #psychotic disorder
#Mortality Risk Among Women With #Premenstrual Disorders in Sweden
Key PointsQuestion Do women with premenstrual disorders (PMDs) have higher risks of all-cause and cause-specific mortality compared with women without PMDs?Findings This nationwide matched cohort study of 406 488 women in Sweden during a mean (SD) follow-up of 6.2 (4.6) years (range, 1-18 years) revealed that overall, women with diagnosed PMDs did not have an increased risk of… Continue reading #Mortality Risk Among Women With #Premenstrual Disorders in Sweden
‘Death by 1000 Cuts’: Medscape National #Physician #Burnout & #Suicide Report 2021
Long-term exposure to residential #greenness and decreased risk of #depression and #anxiety
Residential greenness is considered a unique and potentially modifiable exposure construct to reduce physiological stress and improve human health. Here this study aims to investigate the longitudinal relationships of residential greenness with incident depression and anxiety and to explore and compare the pathways in which greenery may influence mental health. After excluding participants with depression… Continue reading Long-term exposure to residential #greenness and decreased risk of #depression and #anxiety
Impact of #Mental Health Treatment on Outcomes in Patients With #Heart Failure and Ischemic Heart Disease
BackgroundThere is conflicting evidence as to the impact of mental health treatment on outcomes in patients with heart disease. The aim of this study was to examine whether individuals who received mental health treatment for anxiety or depression after being hospitalized for ischemic disorders or heart failure had a reduced frequency of rehospitalizations, emergency department… Continue reading Impact of #Mental Health Treatment on Outcomes in Patients With #Heart Failure and Ischemic Heart Disease
Most #GLP-1 Medications Correlated with a Lower Likelihood of #Anxiety and #Depression Diagnoses
Key FindingsDiabetic patients prescribed tirzepatide, semaglutide, dulaglutide, and exenatide are less likely to be diagnosed with depression after starting the medication compared to those not on a glucagon-like peptide-1 receptor agonist (GLP-1) medication. The likelihood of anxiety in diabetic patients is lower for those on all five GLP-1 medications studied. Among non-diabetic patients, semaglutide is correlated with… Continue reading Most #GLP-1 Medications Correlated with a Lower Likelihood of #Anxiety and #Depression Diagnoses
Polygenic predisposition, #sleep duration, and #depression: evidence from a prospective population-based cohort
Suboptimal sleep durations and depression frequently cooccur. Short-sleep and long-sleep are commonly thought of as symptoms of depression, but a growing literature suggests that they may be prodromal. While each represents a process of mutual influence, the directionality between them remains unclear. Using polygenic scores (PGS), we investigate the prospective direction involved in suboptimal sleep… Continue reading Polygenic predisposition, #sleep duration, and #depression: evidence from a prospective population-based cohort
2 Medical News 